ADMA Biologics ADMA Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's other operating expenses?
- ADMA Biologics (ADMA) reported other operating expenses of $22.48M in Q1 2026.
- How has ADMA Biologics's other operating expenses changed year-over-year?
- ADMA Biologics's other operating expenses decreased by 14.3% year-over-year, from $26.22M to $22.48M.
- What is the long-term trend for ADMA Biologics's other operating expenses?
- Over 4 years (2021 to 2025), ADMA Biologics's other operating expenses has grown at a 14.2% compound annual growth rate (CAGR), from $59.55M to $101.32M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.